Invention Grant
- Patent Title: Carbazole and carboline kinase inhibitors
- Patent Title (中): 咔唑和咔啉激酶抑制剂
-
Application No.: US13140184Application Date: 2009-12-17
-
Publication No.: US08815840B2Publication Date: 2014-08-26
- Inventor: Ashok Vinayak Purandare , Douglas G. Batt , Qingjie Liu , Harold Mastalerz , Kurt Zimmermann
- Applicant: Ashok Vinayak Purandare , Douglas G. Batt , Qingjie Liu , Harold Mastalerz , Kurt Zimmermann
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen; Mary VanAtten
- International Application: PCT/US2009/068394 WO 20091217
- International Announcement: WO2010/080474 WO 20100715
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/403 ; A61P7/00 ; A61P7/02 ; A61P35/00 ; C07D403/10 ; C07D413/08 ; C07D413/14
Abstract:
The present invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof The Formula (I) compounds inhibit tyrosine kinase activity of Jak2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
Public/Granted literature
- US20120058988A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS Public/Granted day:2012-03-08
Information query
IPC分类:
